(CNCR) Loncar Cancer - Performance -39.4% in 12m
Compare CNCR with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-69.70%
#46 in Group
Rel. Strength
17.74%
#6578 in Universe
Total Return 12m
-39.37%
#47 in Group
Total Return 5y
-57.05%
#47 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: CNCR (-39.4%) vs QQQ (6.9%)

5y Drawdown (Underwater) Chart

Top Performers in Health
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
PPH NASDAQ VanEck Pharmaceutical |
-10.4% | -0.92% | 52.4% | - | - | - | - | - |
XLV NYSE ARCA Health Care Sector SPDR |
-5.82% | 0.93% | 47.8% | - | - | - | - | - |
IHE NYSE ARCA iShares U.S. |
-9.89% | 0.7% | 36.5% | - | - | - | - | - |
IYH NYSE ARCA iShares U.S. Healthcare |
-6.48% | -0.53% | 41.6% | - | - | - | - | - |
VHT NYSE ARCA Vanguard Health Care |
-6.21% | 0.01% | 41.5% | - | - | - | - | - |
FHLC NYSE ARCA Fidelity MSCI Health Care |
-6.3% | -0.24% | 41.1% | - | - | - | - | - |
IXJ NYSE ARCA iShares Global Healthcare |
-6.5% | -0.14% | 35.5% | - | - | - | - | - |
IHI NYSE ARCA iShares U.S. Medical |
-5.23% | 2.33% | 33.3% | - | - | - | - | - |
Performance Comparison: CNCR vs QQQ vs S&P 500
QQQ (Invesco QQQ Trust ETF) is the Sector Benchmark for CNCR
Total Return (including Dividends) | CNCR | QQQ | S&P 500 |
---|---|---|---|
1 Month | -15.97% | -4.99% | -4.92% |
3 Months | -22.09% | -11.23% | -9.03% |
12 Months | -39.37% | 6.90% | 7.93% |
5 Years | -57.05% | 119.52% | 101.72% |
Trend Score (consistency of price movement) | CNCR | QQQ | S&P 500 |
1 Month | -83.8% | -75.6% | -71.8% |
3 Months | -86.8% | -84.6% | -84.5% |
12 Months | -71.0% | 59.4% | 69.5% |
5 Years | -79.0% | 77% | 84.3% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. QQQ | vs. S&P 500 |
1 Month | #45 | -11.6% | -11.6% |
3 Month | #45 | -12.2% | -14.4% |
12 Month | #47 | -43.3% | -43.8% |
5 Years | #47 | -80.4% | -78.7% |
FAQs
Does CNCR Loncar Cancer outperforms the market?
No,
over the last 12 months CNCR made -39.37%, while its related Sector, the Invesco QQQ Trust (QQQ) made 6.90%.
Over the last 3 months CNCR made -22.09%, while QQQ made -11.23%.
Over the last 3 months CNCR made -22.09%, while QQQ made -11.23%.
Performance Comparison CNCR vs Indeces and Sectors
CNCR vs. Indices CNCR is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 5.33% | -11.1% | -32.9% | -47.3% |
US NASDAQ 100 | QQQ | 3.53% | -11.0% | -33.2% | -46.3% |
US Dow Jones Industrial 30 | DIA | 6.38% | -12.5% | -34.7% | -48.1% |
German DAX 40 | DAX | 8.91% | -7.72% | -48.4% | -56.6% |
Shanghai Shenzhen CSI 300 | CSI 300 | 6.30% | -7.53% | -35.5% | -45.6% |
Hongkong Hang Seng | HSI | 6.04% | -4.88% | -32.9% | -53.4% |
India NIFTY 50 | INDA | 9.60% | -19.4% | -29.9% | -39.8% |
Brasil Bovespa | EWZ | 7.55% | -9.96% | -31.2% | -26.6% |
CNCR vs. Sectors CNCR is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 6.67% | -11.0% | -41.3% | -55.4% |
Consumer Discretionary | XLY | 6.49% | -12.1% | -35.5% | -48.8% |
Consumer Staples | XLP | 7.48% | -17.0% | -39.1% | -53.1% |
Energy | XLE | 10.2% | -3.33% | -29.1% | -25.1% |
Financial | XLF | 5.98% | -12.6% | -41.2% | -59.8% |
Health Care | XLV | 10.1% | -10.2% | -30.4% | -40.3% |
Industrial | XLI | 5.08% | -11.3% | -31.8% | -44.5% |
Materials | XLB | 4.78% | -9.26% | -24.3% | -31.4% |
Real Estate | XLRE | 6.17% | -11.0% | -31.1% | -52.0% |
Technology | XLK | 1.84% | -9.38% | -27.7% | -39.8% |
Utilities | XLU | 7.33% | -14.8% | -37.4% | -65.2% |
Aerospace & Defense | XAR | 2.69% | -15.8% | -42.1% | -63.7% |
Biotech | XBI | 3.95% | -2.67% | -16.7% | -28.1% |
Homebuilder | XHB | 8.64% | -8.87% | -13.5% | -28.6% |
Retail | XRT | 7.85% | -11.3% | -25.5% | -33.5% |